Clinical Trials Browser

Recruiting × Interventional × Cardiovascular Diseases × Clear all

NCT06856902 2026-04-01

BEAMER

Phase NA Recruiting

Treatment Adherence and Compliance, Cardiovascular Diseases, Neoplasms, Rare Diseases

NCT07464132 2026-03-11

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Phase 1/2 Recruiting

Cardiomyopathy, Hypertrophic, Cardiovascular Diseases, Neoplasms, Pulmonary Fibrosis

NCT06648278 2026-01-13

COUNTS2

Phase NA Recruiting

Breast Neoplasms, Cardiovascular Diseases

NCT05174286 2025-09-16

CHURCH

Phase NA Recruiting

Gastrointestinal

Cardiovascular Diseases, Colorectal Neoplasms

NCT05432856 2025-08-27

IMPACT-Women

Phase NA Recruiting

Cardiovascular Diseases, Metabolic Diseases

NCT05802121 2025-08-20

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Phase EARLY_PHASE1 Recruiting

GenitourinaryOther

Bone Diseases, Cardiovascular Diseases, Diabetes Mellitus, Hyperlipidemias, Obesity, Prostatic Neoplasms, Metabolic Syndrome

NCT06202820 2025-08-11

CV CARE: CardioVascular Care in PC Patients

Phase NA Recruiting

Cardiovascular Diseases, Prostatic Neoplasms

NCT05945121 2025-05-02

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Phase NA Recruiting

Cardiovascular Diseases

NCT03127631 2025-01-31

RADICALPC

Phase NA Recruiting

Cardiovascular Diseases, Prostatic Neoplasms

NCT06338215 2024-12-12

UNATI

Phase NA Recruiting

10,000 enrolled

Cardiovascular Diseases, Dementia, Depression, Diabetes Mellitus, Type 2, Infections, Liver Cirrhosis, Tuberculosis, Wounds and Injuries

NCT06645691 2024-12-06

POLARIC-13

Phase 2 Recruiting

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome

NCT05632601 2024-11-04

HER-CROWN

Phase NA Recruiting

BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT06644443 2024-10-16

BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma

Phase 1/2 Recruiting

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT06271252 2024-08-02

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

Phase 1 Recruiting

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT06270667 2024-03-22

LYMfit

Phase NA Recruiting

Cardiovascular Diseases, Lymphoma, Motor Activity, Cardiotoxicity